Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
Human Type I Interferon Neutralizing Antibody Mixture
Human Type I Interferon Neutralizing Antibody Mixture from PBL Assay Science
Be the first to write a review!
Citations:
(12)
Supplier Page
Supplier Page from
PBL Assay Science for
Human Type I Interferon Neutralizing Antibody Mixture
Get Pricing
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Human Type I Interferon Neutralizing Antibody Mixture
Company
PBL Assay Science
Price
$645.00
Supplier Page
View Company Product Page
Catalog Number
39000-1
Quantity
0.2 ml
Applications
Neutralization
Conjugate/Tag
Unconjugated
Reactivity
Human
Add to Compare List
PBL Assay Science
131 Ethel Road West. Suite 6
Piscataway
,
New Jersey
United States
Phone
: 1-877-725-8881
1-732-777-9123
1-732-777-9141
Company Profile
Website:
www.pblassaysci.com
Citations (12)
(1)
Interferon-β induction heterogeneity during KSHV infection is correlated to levels and activation of the transcription factors ATF2 and RelA, and not IRF3
PLOS Pathogens
February 11, 2026
Machika Kaku, Marta Maria Gaglia
S777525MG), a mixture of neutralizing antibodies against type I IFNs at
1:2000
dilution (
PBL Assay Science
39000–1
), 10 μM
TBK1
inhibitor
(
MRT67307
;
Medchemexpress
LLC HY130185MG), 10 μM cGAS
inhibitor
(
G140
; Invivogen
(2)
Genetic ancestry shapes dengue virus infection in human skin explants
Proceedings of the National Academy of Sciences of the United States of America
July 15, 2025
Castanha PMS, Martí MM, Duangkhae P, Taddonio JM, Cooper KL, Wallace M, Kettenburg G, Erdos G, Chavva H, Alex A,
et al
.
(
R&D Systems
,
201-LB-005-CF
), 20 μg of neutralizing antibody to
human
type 1 IFN (
PBL Assay Science
,
39000-1
), 30 ng of neutralizing antibody to
human
IL-1β (
R&D Systems
,
MAB601
-25), 30 ng isotype control antibody
(3)
Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer
Molecular Therapy: Oncology
September 19, 2024
Karen Geoffroy, Victor Mullins-Dansereau, Kim Leclerc-Desaulniers, Mélissa Viens, Marie-Claude Bourgeois-Daigneault
(
11410-2
,
PBL assay science
, Piscataway, NJ) or a mixture of
human
type I
IFN
neutralizing antibodies (
39000-1
,
PBL assay science
) were also used at the indicated concentrations for some experiments. In all cases,
(4)
Interferons prime the endothelium for toll-like receptor–mediated thrombin generation
Journal of Thrombosis and Haemostasis
April 1, 2024
Kelsey D. Sack, Nathan Eaton, Maneli Doroudian Tehrani, Robert Flaumenhaft
anti-type I IFN antibodies (including antibodies to IFNα, IFNβ, IFNω, IFNκ, IFNε;
PBL Assay Science
,
39000–1
) or Type II IFN antibody (anti-IFNγ,
PBL Assay Science
,
31500–1
) for 3 hours, and incubated on ECs for
(5)
Caspase-Mediated Regulation and Cellular Heterogeneity of the cGAS/STING Pathway in Kaposi's Sarcoma-Associated Herpesvirus Infection
mBio
December 20, 2022
Tabtieng T, Lent RC, Kaku M, Monago Sanchez A, Gaglia MM.
dilutions of a mixture of neutralizing antibodies against type I IFNs (
PBL Assay Science
, catalog number
39000-1
). The concentrations of all drug treatments were chosen based on common concentrations used in previously
(6)
Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract
Emerging microbes & infections
December 1, 2022
Essaidi-Laziosi M, Alvarez C, Puhach O, Sattonnet-Roche P, Torriani G, Tapparel C, Kaiser L, Eckerle I.
similar dual
assays
were repeated where a mixture of anti-type I neutralizing antibodies diluted 1/50 (
39000-1
,
PBL
Assay
ScienceTM, Piscataway, NJ, USA) and 10μg/mL of anti-IFN-λ1 (MAB15981-100, RandD, Minneapolis,
(7)
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses
Science advances
February 25, 2022
Nguyen LC, Yang D, Nicolaescu V, Best TJ, Gula H, Saxena D, Gabbard JD, Chen SN, Ohtsuki T, Friesen JB,
et al
.
μg/ml) (MAB285-100), and
1:25
dilution of
Human
Type I IFN Neutralizing Ab Mixture (
PBL Assay Science
,
39000-1
) 2 hours before
infection
. Cells were then infected with 0.5 MOI and incubated for 24 hours, after which
(8)
SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response
Nat Aging
February 1, 2022
Tsuji S, Minami S, Hashimoto R, Konishi Y, Suzuki T, Kondo T, Sasai M, Torii S, Ono C, Shichinohe S,
et al
.
inhibitor
tocilizumab (Selleck, A2012; 50 μg ml−1), type I IFN neutralization antibody (
PBL Assay Science
,
39000-1
;
1:200
) and the p38 MAP kinase inhibitor
SB203580
(
Selleck
,
S1076
; 10 μM) were administrated at the
(9)
Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells
Science Immunology
April 2, 2021
Tae Jin Yun et al.
ICAM-3 (
clone
: CBR-IC3/1, eBioscience), CD62 E/P-selectin (
clone
: BBIG-E6 (13D5), R&D) and IFN-I/IFNAR2 (
39000-1
,
PBL
) for 30 minutes, or with 3 μM single-stranded oligodeoxynucleotides ODN 20958 (TLR7 antagonist,
(10)
Role of MDA5 in regulating CXCL10 expression induced by TLR3 signaling in human rheumatoid fibroblast-like synoviocytes
Molecular Biology Reports
January 1, 2021
Tatsuro Saruga, Tadaatsu Imaizumi, Shogo Kawaguchi, Kazuhiko Seya, Tomoh Matsumiya, Eiji Sasaki, Norihiro Sasaki, Ryoko Uesato, Yasuyuki Ishibashi
was obtained from BIOWEST (Nuaille, France).
Human type I interferon neutralizing antibody mixture
(
39000-1
) was purchased from
PBL Assay Science
(Piscataway, NJ, USA). Small interfering RNA (siRNA) against MDA5
(11)
Interferon-Dependent and Respiratory Virus-Specific Interference in Dual Infections of Airway Epithelia
Scientific reports
June 24, 2020
Essaidi-Laziosi M, Geiser J, Huang S, Constant S, Kaiser L, Tapparel C.
MAB15981-100
;
R&D Systems
, Minneapolis, MN, USA) and a mixture of anti-type I IFN-neutralizing antibodies (
39000-1
,
PBL Assay Science
) diluted 1/50 in the basal sample during the pretreatment.
Virus
RNA load quantification.
(12)
Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease
Nature communications
October 17, 2019
Szabo PA, Levitin HM, Miron M, Snyder ME, Senda T, Yuan J, Cheng YL, Bush EC, Dogra P, Thapa P,
et al
.
cells were pre-incubated with
Human
Type 1 IFN Neutralizing Antibody Mixture (
PBL Assay Science
, Cat#
39000-1
) according to manufacturer’s instructions, or 1 µg/mL of both anti-IFNγ (
R&D Systems
,
MAB285
,
clone
<<
<
>
>>
Reviews
Be the First to Write a Review!
Human Type I Interferon Neutralizing Antibody Mixture from PBL Assay Science
Supplier Page
View Company Product Page
$645.00
Product Specs
Company Info
Citations
Reviews
Back To Top